Trump Administration Is Taking Billions in Stakes in Firms Like Intel

Intel has denied allegations from TSMC that one of its executives leaked trade secrets, a claim that could have significant implications for both companies in the competitive semiconductor industry. Intel's response aims to protect its reputation and maintain trust among its partners and customers.

Health insurance company stocks experienced a rise on Wednesday, fueled by optimism that the Trump administration and Congress may reach an agreement on extending tax credits for those purchasing insurance through Obamacare. This development reflects ongoing negotiations surrounding healthcare subsidies that are crucial for many Americans.

The Trump administration has announced negotiated prices for 15 drugs under Medicare, which could have saved the program $12 billion last year, reducing spending on these medications by 44%. The list includes popular inhalers like Breo Ellipta and treatments for various conditions including cancer and diabetes.

OpenAI has responded to a lawsuit from the family of Adam Raine, a 16-year-old from California who tragically took his own life, stating that the incident was due to the 'misuse' of its ChatGPT technology and not caused by the chatbot itself.

Stellantis has issued a warning that the European auto industry is facing a critical threat that could lead to its destruction, citing challenges such as regulatory pressures and competition from global markets. This comes as U.S. automakers have adapted to tariffs imposed by the Trump administration, which has focused on taxing auto imports.

Tech giants are increasingly cautious about overinvesting in artificial intelligence (AI) infrastructure, drawing lessons from Intel's past missteps. The Wall Street Journal highlights concerns that excessive spending could lead to financial pitfalls, as companies navigate the rapidly evolving AI landscape.

Tech giants are increasingly cautious about overinvesting in artificial intelligence (AI) infrastructure, drawing lessons from Intel's past missteps. The Wall Street Journal highlights concerns that excessive spending could lead to financial pitfalls, as companies may prioritize AI investments without fully assessing their long-term viability.